The Food and Drug Administration has deemed MDMA a “breakthrough therapy” in the treatment of post-traumatic stress disorder, or PTSD, putting it on a fast track for possible approval. MDMA is also known by the street name Ecstasy. “MDMA opens up a space where people feel safe, they feel better about themselves, and they feel better about other people…,” said Dr. Charles Raison, a psychiatrist and member of the scientific advisory board of MAPS, which stands for Multidisciplinary Association for Psychedelic Studies.
Office of Strategic Communication